Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) EBITDA Margin (2016 - 2020)

Glucotrack's EBITDA Margin history spans 7 years, with the latest figure at 617525.77% for Q2 2020.

  • For the quarter ending Q2 2020, EBITDA Margin fell 61671835.0% year-over-year to 617525.77%, compared with a TTM value of 123513.87% through Dec 2020, down 12522349.0%, and an annual FY2019 reading of 1709.62%, up 1702847.0% over the prior year.
  • EBITDA Margin for Q2 2020 was 617525.77% at Glucotrack, down from 32888.68% in the prior quarter.
  • The five-year high for EBITDA Margin was 9599.1% in Q4 2019, with the low at 617525.77% in Q2 2020.
  • Average EBITDA Margin over 5 years is 45380.89%, with a median of 2763.6% recorded in 2019.
  • Year-over-year, EBITDA Margin surged 1622378bps in 2018 and then plummeted -61671835bps in 2020.
  • Tracing GCTK's EBITDA Margin over 5 years: stood at 892.92% in 2016, then skyrocketed by 532bps to 3861.38% in 2017, then tumbled by -428bps to 12658.92% in 2018, then surged by 176bps to 9599.1% in 2019, then plummeted by -6533bps to 617525.77% in 2020.
  • Per Business Quant, the three most recent readings for GCTK's EBITDA Margin are 617525.77% (Q2 2020), 32888.68% (Q1 2020), and 9599.1% (Q4 2019).